Microsoft, Telefonica announce new AI and edge computing partnership

Telefónica will expand the use of Microsoft’s Azure Cognitive Services over all customer relationship channels The companies will also work to develop Telefónica’s smart applications for connected home devices Mi....

Morphic to collaborate with Janssen to develop integrin therapeutics

Morphic has attained leadership position in the development of oral integrin inhibitors with the help of the ground-breaking structural research Morphic Therapeutic, the Massachusetts-based biotechnology company recently announced that it ....

Facebook updates location settings, adds privacy controls on Android

A few Android users had expressed concern over the app’s capability to continuously record location data in the background Facebook has previously tracked the location of users deemed to be threats Social media giant Facebook has....

JAYS Group to acquire connected audio and speaker brand CLINT® Digital

Premium headphones and app company, JAYS Group AB, has reportedly entered into a binding agreement for acquiring CLINT® Digital, the award-winning lifestyle audio brand from Denmark. The CLINT® brand, to become a part of JAYS Group ....

AzurRx doses first patients in Phase II OPTION study for EPI therapy

AzurRx BioPharma, Inc. has recently informed that the company has dosed the first patients in its Phase II OPTION clinical study aimed at investigating MS1819-SD in cystic fibrosis (CF) patients who experience exocrine pancreatic insufficie....

Indivior introduces generic version of its Suboxone opioid drug

The company said its launch of an authorize generic version of the drug would prompt other firms to introduce their own cheaper versions The announcement comes in backdrop of a court ruling that allowed its rivals to sell generic version....

Philippines FDA bans Sanofis dengue vaccine due to compliance issue

Reports confirm that the Philippines has revoked the product license for Dengvaxia, the dengue vaccine from Sanofi, after the France-based pharmaceutical company failed to comply with directives of regulators. Apparently, the sale, distribu....

CASI Pharma gets NMPA’s nod to conduct confirmatory trial of ZEVALIN®

The firm previously secured greater China rights to ZEVALIN® from Spectrum and aims to launch ZEVALIN® in the country. CASI Pharmaceuticals is currently addressing certain stipulations prescribed by the Center for Drug Evaluatio....

Inventiva declares results of Phase IIb clinical trial of lanifibranor

The FASST clinical trial failed to meet its primary endpoint of a mean absolute change from baseline to week 48 The French clinical-stage biopharmaceutical firm Inventiva has reportedly declared the results from the ‘For A Systemic S....

Miromico, Renesas unveil partnership to produce new LoRa-based module

Miromico and Renesas have recently confirmed that the companies have collaborated and produced a low-power and compact FMLR-61-x-RSS3 module that will allow customers to connect to LoRaWAN-based networks easily. The module is reportedly bas....